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Introduction
Bacterial arthritis is the most rapidly progressive destruc-
tive joint disease in man. Clinical symptoms of septic
arthritis include red, swollen, warm, painful and dysfunc-
tional joints. Other destructive joint diseases, including
rheumatoid arthritis, are connected to an increased inci-
dence of bacterial arthritis. Indeed, the yearly incidence of
arthritis in the general population is 0.002–0.01% but
0.03–0.07% in patients with rheumatoid arthritis, and mor-
tality continues to be high (10–16%) [1].
Staphylococcus aureus is the most common bacterium
that causes septic arthritis. Staphylococci produce a
large number of extracellular and cell-associated mole-
cules that may contribute to virulence [2–4]. These
factors enable the bacteria to evade host defenses, and
thus to establish infection, but they may also trigger a
cascade of host proinflammatory and immunomodulating
molecules [2].
Peptidoglycan (PGN) is the major component of the cell
wall of Gram-positive bacteria and is composed of long
sugar chains of alternating N-acetylglucosamine and N-
acetylmuramic acid residues, which are highly cross-linked
via peptide side chains. The peptide side chain consists of
alternating L- and D-amino acids, up to four or five in
length, and is connected to the COOH group of N-acetyl-
muramic acid. Among different bacterial species, the
structure of the sugar chains is highly conserved, while the
composition of the peptide subunits varies [5]. Some
recent reports indicate that staphylococcal PGN and
lipoteichoic acid (LTA) activate leukocytes, stimulate the
generation of proinflammatory cytokines, and hence,
cause an inflammatory response [6–8]. Indeed, PGN and
LTA are essential in the induction of nitric oxide synthase,
shock, and multiple organ failure [9].
To investigate the possible role of staphylococcal PGN
during septic arthritis, we have intra-articularly administered
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PGN from S. aureus into murine knee joints. Our results
show that staphylococcal PGN induces arthritis. In addi-
tion we show that this condition is mediated by concerted
action of macrophages and acquired immunity.
Materials and methods
Mice and reagents
BALB/c, C57BL/6, and NMRI mice were purchased from
ALAB (Stockholm Sweden). SCID mice and their con-
genic strain CB17 were purchased from M&B
(Bomholtvej, Denmark). All mice were housed in the
animal facility of the Department of Rheumatology (Univer-
sity of Göteborg, Sweden). Male mice, six to eight weeks
old, were used in all experiments. The hybridoma cells
secreting Rb6-8C5 were a kind gift from Dr R Coffman
(DNAX Research Institute, Palo, CA, USA). Hybridoma
PK136 was obtained from Dr Sjögren-Jansson (Wallen-
berg Laboratory, Göteborg, Sweden). Etoposide was pur-
chased from Bristol-Myers Squib (Bromma, Sweden). The
PGN and fragments of PGN were prepared as previously
described [9,10]. LTA was obtained from Sigma Chemical
Co (St Louis, MO, USA).
Injection protocol
PGN dissolved in phosphate buffered saline (PBS) in a
volume of 10 µl was injected intra-articularly in the knee
joints of different mice. The contralateral knee joint was
always used as a negative control, and was injected with
same volume of PBS. All the intra-articular injections were
performed on anesthetized mice approaching from the
frontal aspect of the knee joint, just below the patella.
Histopathological examination
After routine fixation, decalcification, and paraffin embed-
ding, tissue sections from knee joints were cut and stained
with hematoxylin and eosin [3]. All of the slides were coded
and assessed in a blinded manner. The specimens were
evaluated with regard to synovial hypertrophy, pannus for-
mation, and cartilage-subchondral bone destruction. The
extent of synovitis was judged on an arbitrary scale, from
grade 0 (no signs of inflammation) and grade 1 (mild
inflammation characterized by hyperplasia of the synovial
lining layer), to grades 2 and 3 (increasing degree of
extended inflammation characterized by influx of inflamma-
tory cells scattered throughout the synovial tissue).
Immunohistochemical examination
The knee joints were removed and demineralized by enzy-
matic procedures detailed previously [3]. The demineral-
ized specimens were mounted on cryostat chucks, frozen
in isopentane that had been prechilled in liquid nitrogen,
and kept at –70ºC until cryosectioned. Serial cryosection
6 µm thick were stained with a monoclonal rat antibody to
mouse CD11b (Mac-1), CD4 (GK1.5), CD8 (53.6.7)
followed by incubation with biotinylated secondary anti-
bodies, avidin–biotin–peroxidase complexes, and 3-amino-
9-ethyl-carbazole containing H2O2. All sections were
counterstained with Mayer´s hematoxylin [3].
Monocyte depletion
Etoposide is a cytotoxic drug known to selectively deplete
the monocyte population [11]. C57B1/6 mice were subcuta-
neously injected with 12.5 mg/kg body weight of etoposide
on 3 consecutive days before intra-articular injection with
PGN and on either 2 or 5 consecutive days after it. Control
mice received the same volume of the vehicle. Flow cytome-
try analysis revealed that peripheral blood monocytes
decreased significantly as compared with the numbers in
controls (10.5 × 104 ml versus 51.7 × 104 ml, P < 0.01).
Neutrophil depletion
The mAb RB6-8C5 is a rat IgG2b that selectively binds to
and depletes mature mouse neutrophils and eosinophils
[12]. BALB/c mice were injected intraperitoneally with
1 mg of either mAb RB6-8C5 or the IgG rat anti-ovalbu-
min mAb as a control, 2 hours prior to intra-articular injec-
tion with PGN. This procedure depleted neutrophils by
90% as previously reported [12].
Natural killer-cell depletion
Natural killer (NK)-cell depletion was performed by
intraperitoneal inoculation with 200 µg PK136 mAb, 1 day
prior to and 2 days after intra-articular injection of PGN in
C57B1/6 mice. The O1C5B2 mAb was used as control
[4,13]. This procedure has been shown to reduce the
number of NK cells by 90% [13].
Statistical analyses
The differences between mean values were tested for sig-
nificance with the Student’s two-tailed t–test. P < 0.05
was considered as significant.
Results
Induction of arthritis by S. aureus peptidoglycan
S. aureus PGN was directly injected into murine knee
joints. Within one day, joints were found to be macroscop-
ically swollen and the swelling lasted for 10 days after
intra-articular inoculation of 100 µg of PGN.
Histopathological analysis revealed a very strong synovial
inflammation (Fig. 1b) and frequent occurrence of granulo-
mas when arthritis was induced by 100 µg of PGN. There
was synovial hypertrophy and occurrence of infiltrating
cells in the synovial lining cell layer, deep in the sublining
space, as well as in surrounding synovial vessels in
arthritic joint sections. Granulomas were found in the
majority of samples, and in a few samples (6 of 18)
pannus formation, cartilage and/or bone destruction was
visible. Arthritis triggered by 100 µg PGN was visible
within 2 hours after the injection and lasted for at least
2 weeks. The maximal frequency and severity of arthritis
were noted on day 3 after the injection (Fig. 2).
To assess the optimal amount of PGN for triggering arthri-
tis, different doses of PGN (0, 1, 10, 25, 50, 75,
100 µg/knee) were used in one experiment. Fifty percent
of mice developed arthritis after injection of 1 and 10 µg.
Severity of arthritis is 0.5 ± 0.58, 0.75 ± 0.96, respec-
tively. The dose of 25 µg or more gave rise to arthritis in all
the knee joints analyzed.
We examined 6 different mouse strains, including Swiss,
BALB/c, C57B1/6, C3H/HeN, C3H/HeJ and CB17 to
assess their susceptibility to arthritis. We found that arthri-
tis was induced by PGN in all of these strains.
Immunohistochemical features of arthritic joints
The majority of the lining cells in the nonproliferative syn-
ovial tissue was stained with Mac-1, recognizing resident
macrophages. T lymphocytes were not observed in
healthy synovium. In sections of arthritic joints, a large
population of synovial cells was stained with Mac-1
(Fig. 1c). These cells, which have a morphology of macro-
phage (i.e. mononuclear cells), were found both within the
thickened synovial lining layer and within the deeper syn-
ovial tissue, The predominance of Mac-1+ cells was
evident at all stages of inflammation. A few CD4+ and
CD8+ T cells were also found.
The role of immune cells in the development of arthritis
triggered by peptidoglycan
Immunohistochemical results from joints injected with
PGN demonstrated that there was an abundance of
Mac-1+ cells and few T lymphocytes at all stages of arthri-
tis. These data suggest that Mac-1+ cells and T lympho-
cytes might play a role in the development of
PGN-triggered arthritis.
We used etoposide to deplete the monocyte population
and thereby assess the role of tissue infiltrating
macrophages. Despite 80% depletion of monocytes,
however, the incidence and severity of arthritis were not
different between monocyte-depleted and control mice
(Table 1).
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Figure 1
Photomicrographs showing the histopathologic and immunohistochemical features of arthritis induced by peptidoglycan. (a) Normal
histopathologic appearance of a mouse knee joint following injection with phosphate-buffered saline. (b) Histopathology of an arthritic knee joint of
a mouse 3 days after intra-articular inoculation with peptidoglycan, showing infiltration of inflammatory cells in synovial tissue and granulomas within
the synovium. (c) Immunohistochemistry of an arthritic knee joint, showing synovial expansion of Mac-1-expressing cells three days after intra-
articular inoculation with peptidoglycan. JC, joint cavity; C, cartilage; ST, synovial tissue.
Figure 2
Kinetics of arthritis induced by peptidoglycan (n = 4 per group) in
NMRI mice. Values are shown as mean ± SD.
To assess the role of neutrophils, we used RB-8C5 anti-
body to deplete these cells. Again neutrophil-depleted
mice did not differ from control mice in their development
of arthritis mediated by PGN (Table 1). We next deter-
mined whether NK cells exert any role in arthritis triggered
by PGN. We depleted NK cells using PK136 antibody,
and as shown in Table 1, the incidence and severity of
arthritis were not different between NK-cell-depleted mice
and the control mice. We also assessed the role of T and
B cells using SCID mice, which lack T and B cells but
have an intact population of macrophages and NK cells.
Histopathologic results from SCID mice and their con-
genic littermates (CB17) demonstrated that the severity
and incidence of arthritis were not significantly different
between the groups (Table 1).
Lastly, to evaluate the role of synergism of immune cells in
the development of arthritis mediated by PGN, the follow-
ing experiment using SCID mice was performed. RB6-
8C5 antibody and etoposide were used to deplete
neutrophils and macrophages in SCID and BALB/c mice.
The results demonstrate that the incidence and severity of
arthritis mediated by PGN in monocyte-depleted and neu-
trophil-depleted SCID mice were significantly reduced
(P < 0.05) (Table 2). When neutrophils alone were
depleted in SCID mice, the incidence and severity of
arthritis mediated by PGN did not show a clear difference
compared with the control group. In contrast, macrophage
alone depletion in SCID mice resulted in decreased inci-
dence and severity of arthritis mediated by PGN com-
pared with control group. These results provide strong
evidence for the synergistic role of monocyte/macrophage
and T/B lymphocytes in initiating and maintaining arthritis
triggered by PGN.
Digested peptidoglycan does not induce arthritis
To further elucidate the structural elements of PGN that
are essential to induce arthritis, PGN (9 mg/ml) from
S. aureus was digested for 18 hours with lysostaphin
(150 µg/ml) or cellosyl (150 µg/ml) before intra-articular
injection into knee-joints. Lysostaphin was used to hydrol-
yse the glycine crossbridge of the PGN, resulting in long
chains of soluble material [9]. Cellosyl is a muramidase
that hydrolyses the bond between N-acetylglucosamine
and N-acetylmuramic acid, producing small soluble
muropeptides (some of which are crosslinked) [10]. We
used these enzymes to digest PGN into different frag-
ments and analysed whether these fragments are respon-
sible for the inflammatory response. Our results, however,
showed that the fragments from PGN digested by either
lysostaphin or cellosyl did not give rise to any inflammatory
response in joints (Fig. 3).
Discussion
The purpose of this work was to investigate the role of
PGN from S. aureus in the induction of arthritis. Our
results reveal that it induces joint inflammation, and it may,
therefore, play an important role in septic arthritis.
The synergistic effect of macrophages and T cells is essen-
tial to trigger arthritis. There are several lines of support for
this suggestion. Arthritis occurs within 2 hours after admin-
istration of PGN, rendering it highly improbable that
immune responses mediated by lymphocytes alone would
trigger such a process without prior exposure. This rapid
onset of arthritis indicates that innate immune responses
are involved at this stage of disease. Also, our experiment
demonstrated that absence of either neutrophils, NK cells,
monocytes, or T/B cells does not significantly affect the
development of arthritis induced by PGN. In contrast,
depletion of circulating monocytes in SCID mice
decreased by half the prevalence of arthritis. These find-
ings are further supported by immunohistochemical analy-
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Table 2
The incidence and severity of arthritis after intra-articular
injection of 100 µg peptidoglycan to SCID mice depleted of
neutrophils and monocytes
Number
Group of mice Incidence (%) Severity
CB17 10 100 2.8 ± 0.4
SCID + RB6-8C5 10 100 1.6 ± 0.5
SCID + etoposide 8 50 0.5 ± 0.5
SCID+ RB6-8C5 + 8 50 0.6 ± 0.7
etoposide
BALB/c+RB6-8C5 + 10 70 1.5 ± 1.1
etoposide
Table 1
The frequency and severity of arthritis triggered by intra-
articular injection of 100 µg of peptidoglycan in mice depleted
of neutrophils, NK cells, or monocytes 
Group Mice Incidence Severity
RB6-8C5 BALB/c 10/10 2.0 ± 0.7
Control BALB/c 9/9 2.3 ± 0.8
PK136 C57BL/6 10/10 1.8 ± 0.8
Control C57BL/6 10/10 2.2 ± 0.6
Etoposide C57BL/6 8/8 1.6 ± 0.7
Control C57BL/6 10/10 2.1 ± 0.5
SCID CB17 9/9 1.6 ± 0.7
Control CB17 10/10 2.7 ± 0.5
RB6-8C5 is an IgG2b antibody that depletes neutrophils in BALB/c
mice. Etoposide is a cytotoxic drug that selectively depletes
monocytes. PK136 is an IgG2a antibody that depletes natural killer
cells. SCID mice lack T and B cells.
sis showing that PGN-triggered arthritis was characterised
by an influx of mononuclear Mac-1+ and CD4+ cells.
Several studies have shown that staphylococcal PGN stim-
ulates human monocytes to release tumour necrosis factor-
alpha (TNF-α), IL-1, and IL-6 [7,8,14], and that T cells
producing TNF-α and IL-1 in response to stimulation with
Gram-positive bacterial cell wall components [15] are
known to exert proinflammatory activities in septic [16], and
aseptic arthritis [17,18], being able to mediate cartilage
and bone destruction. Indeed, it has been demonstrated
that a single intra-articular injection of TNF-α or IL-1
induces acute synovitis [19,20], whereas neutralisation of
TNF-α decreases the severity of the inflammation and joint
destruction in collagen-II-induced-arthritis [2,22].
Surprisingly, in this study we found that fragments from
PGN digested with lysostaphin or cellosyl do not induce
arthritis. Previous studies demonstrated that the endopep-
tidase lysostaphin significantly enhanced the nitrite forma-
tion [9]. Interestingly, these results indicate that there are
clearly different mechanisms between PGN-induced local
inflammatory response and PGN-induced systemic inflam-
matory response.
Our results demonstrate that PGN induces arthritis and
suggest an important pathogenic role for this molecule in
septic arthritis. Moreover, in the cases of reactive arthritis
and rheumatoid arthritis, the role of PGN as a perpetuat-
ing stimulus for a local inflammatory response in the joints
should be evaluated. Our findings may have implications
for the treatment of bacterial arthritides. Eradication of
bacteria using antibiotics might not be sufficient to elimi-
nate disease symptoms, since the proinflammatory bacter-
ial products including PGN released from resident
bacteria in concert with bacterial DNA, might promote a
continuous inflammatory response. Indeed, previous epi-
demiological studies have indicated that despite antibiotic
treatment, and therefore eradication of all live bacteria,
inflammation and joint destruction continue [1]. Some clin-
ical studies suggest in fact that irrigation of joints might be
beneficial in cases of septic arthritis [23]. One potential
effect of such irrigation would be to decrease the local
levels of PGN. Further treatment strategies should include
attempts to minimize bacterial growth, together with block-
ade of the proinflammatory effect of PGN.
Conclusion
Our results indicate that S. aureus PGN exerts a central
role in joint inflammation triggered by S. aureus and this
condition is mediated by the combined impact of the
acquired (T and B cells) and the innate (monocytes/
macrophages) immune systems.
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